Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMISULPRIDE Cause Wrong patient received product? 37 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Wrong patient received product have been filed in association with AMISULPRIDE (Barhemsys). This represents 1.2% of all adverse event reports for AMISULPRIDE.

37
Reports of Wrong patient received product with AMISULPRIDE
1.2%
of all AMISULPRIDE reports
9
Deaths
21
Hospitalizations

How Dangerous Is Wrong patient received product From AMISULPRIDE?

Of the 37 reports, 9 (24.3%) resulted in death, 21 (56.8%) required hospitalization, and 1 (2.7%) were considered life-threatening.

Is Wrong patient received product Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does AMISULPRIDE Cause?

Drug ineffective (665) Weight increased (346) Toxicity to various agents (305) Suicide attempt (261) Akathisia (252) Extrapyramidal disorder (226) Drug abuse (219) Leukopenia (218) Therapeutic product effect incomplete (200) Off label use (191)

What Other Drugs Cause Wrong patient received product?

INSULIN LISPRO (334) CLOZAPINE (198) RISPERIDONE (176) OXAZEPAM (152) BISOPROLOL (150) LEVETIRACETAM (126) ACETAMINOPHEN (123) METFORMIN (116) INSULIN GLARGINE (114) CLONAZEPAM (112)

Which AMISULPRIDE Alternatives Have Lower Wrong patient received product Risk?

AMISULPRIDE vs AMITRIPTYLINE AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE AMISULPRIDE vs AMIVANTAMAB AMISULPRIDE vs AMIVANTAMAB-VMJW AMISULPRIDE vs AMLODIPINE

Related Pages

AMISULPRIDE Full Profile All Wrong patient received product Reports All Drugs Causing Wrong patient received product AMISULPRIDE Demographics